Malaria treatment

Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

· Novartis and Medicines for Malaria Venture (MMV) announce decision to move to Phase 3 study for novel non-artemisinin combination to treat uncomplicated malaria · This novel combination also contains an optimized formulation of

Prime Business Africa

1 year ago

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Malaria treatment

Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

Featured Stories

Gold Prices Rise As Iran’s Attack On Israel Sparks ‘Safe Haven’ Demand

Nokia CEO Says Humans To Be Implanted With 6G Chips, Sets Timeframe

More Economic Burdens For Nigerians As Prices Remain High Despite Naira Appreciation

Naira Ends Week Positively, Inches Closer To Below ₦1,000/$1 Exchange Rate

Latest News

Ideological Differences Influencing Powerful Nations’ Stance On AI Regulation – Dr Mbamalu

UNN Int’l Conference: Mass Comm Dept Staff, Alumni Pay Courtesy Visit To Vice Chancellor [PHOTOS]

Nigerian Govt, NNPC Refute Marketers, El-Rufai’s Claim of Fuel Subsidy Payment

CBN Slashes Loan-to-Deposit Ratio To 50%, Mandates Banks To Adjust Operations

APC Campaign Council

Categories

Suggestions

Malaria treatment

Follow Us

Featured Stories

Latest News

APC Campaign Council

Categories